Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trialMichel Seymour, Philip Quirke, Stephen J. Gwyther et al.|The Lancet Oncology|2013Cited by 392
Colorectal Endoscopic Stenting Trial (CReST) for obstructing left-sided colorectal cancer: randomized clinical trialHeena Patel, James Hill, S Lee et al.|British journal of surgery|2022Cited by 85
A randomised phase III trial of the pharmacokinetic biomodulation of irinotecan using oral ciclosporin in advanced colorectal cancer: Results of the Panitumumab, Irinotecan & Ciclosporin in COLOrectal cancer therapy trial (PICCOLO)Gary Middleton, Michel Seymour, John Bridgewater et al.|European Journal of Cancer|2013Cited by 24